ACTISKENAN SKENAN

The actual benefit of the proprietary medicinal products ACTISKENAN, hard capsules and SKENAN, prolonged-release microgranules in hard capsules is :

- substantial in the management of severe and/or intractable pain occurring in the context of osteoarthritis of the knee or hip and chronic lumbar pain, as a last-resort treatment, at a stage where surgery is planned or in patients who are not candidates (due to refusal or contraindication) for prosthetic joint replacement surgery (in osteoarthritis of the hip or knee), and for the shortestduration possible due to the risk of serious adverse effects and the absenceof long-term data. This therapeutic category should be used as little as possible, after the other pharmacological treatments and physiotherapy recommended in these indications have failed ;